![Podcast cover](https://cdn-images.owltail.com/200x/jpg/aHR0cHM6Ly9jLnBlZXJ2b2ljZS5jb20vcG9kY2FzdC94bWwvYWxidW0yMDIzL29uY29sb2d5X2hhZW1hdG9sb2d5X2F1ZGlvLmpwZw==.jpg)
Arndt Vogel, MD - Modern Management of Cholangiocarcinoma: Sharing Evidence, Experience, and Expertise
Arndt Vogel, MD - Modern Management of Cholangiocarcinoma: Sharing Evidence, Experience, and Expertise
Arndt Vogel, MD - Modern Management of Cholangiocarcinoma: Sharing Evidence, Experience, and Expertise
31 Jul 2023
•
1hr 15mins
![Podcast cover](https://cdn-images.owltail.com/200x/jpg/aHR0cHM6Ly9jLnBlZXJ2b2ljZS5jb20vcG9kY2FzdC94bWwvYWxidW0yMDIzL29uY29sb2d5X2hhZW1hdG9sb2d5X2F1ZGlvLmpwZw==.jpg)
Javier Cortés, MD, PhD - Updates on HER3-Targeted Therapies in NSCLC and Breast Cancer
Javier Cortés, MD, PhD - Updates on HER3-Targeted Therapies in NSCLC and Breast Cancer
Javier Cortés, MD, PhD - Updates on HER3-Targeted Therapies in NSCLC and Breast Cancer
24 Jul 2023
•
22mins
![Podcast cover](https://cdn-images.owltail.com/200x/jpg/aHR0cHM6Ly9jLnBlZXJ2b2ljZS5jb20vcG9kY2FzdC94bWwvYWxidW0yMDIzL29uY29sb2d5X2hhZW1hdG9sb2d5X2F1ZGlvLmpwZw==.jpg)
Michael K. Wong, MD, PhD, FRCPC - Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations
Michael K. Wong, MD, PhD, FRCPC - Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations
Michael K. Wong, MD, PhD, FRCPC - Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations
18 Jul 2023
•
16mins
![Podcast cover](https://cdn-images.owltail.com/200x/jpg/aHR0cHM6Ly9jLnBlZXJ2b2ljZS5jb20vcG9kY2FzdC94bWwvYWxidW0yMDIzL29uY29sb2d5X2hhZW1hdG9sb2d5X2F1ZGlvLmpwZw==.jpg)
Joe O'Sullivan, MD, PhD, FRCR - Evolving Evidence of Radioligand Therapy in Metastatic Prostate Cancer: A 2023 Clinical Round-Up From Key Congresses
Joe O'Sullivan, MD, PhD, FRCR - Evolving Evidence of Radioligand Therapy in Metastatic Prostate Cancer: A 2023 Clinical Round-Up From Key Congresses
Joe O'Sullivan, MD, PhD, FRCR - Evolving Evidence of Radioligand Therapy in Metastatic Prostate Cancer: A 2023 Clinical ... Read more
18 Jul 2023
•
8mins
![Podcast cover](https://cdn-images.owltail.com/200x/jpg/aHR0cHM6Ly9jLnBlZXJ2b2ljZS5jb20vcG9kY2FzdC94bWwvYWxidW0yMDIzL29uY29sb2d5X2hhZW1hdG9sb2d5X2F1ZGlvLmpwZw==.jpg)
Johnny Mahlangu, MBBCH, MMed, FCPath - Redefining Balance in Hemophilia: Can We Restore Hemostasis by Inhibiting Anticoagulation?
Johnny Mahlangu, MBBCH, MMed, FCPath - Redefining Balance in Hemophilia: Can We Restore Hemostasis by Inhibiting Anticoagulation?
Johnny Mahlangu, MBBCH, MMed, FCPath - Redefining Balance in Hemophilia: Can We Restore Hemostasis by Inhibiting Anticoa... Read more
17 Jul 2023
•
43mins
![Podcast cover](https://cdn-images.owltail.com/200x/jpg/aHR0cHM6Ly9jLnBlZXJ2b2ljZS5jb20vcG9kY2FzdC94bWwvYWxidW0yMDIzL29uY29sb2d5X2hhZW1hdG9sb2d5X2F1ZGlvLmpwZw==.jpg)
Sara A. Hurvitz, MD, FACP - Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Sara A. Hurvitz, MD, FACP - Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Sara A. Hurvitz, MD, FACP - Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
27 Jun 2023
•
18mins
![Podcast cover](https://cdn-images.owltail.com/200x/jpg/aHR0cHM6Ly9jLnBlZXJ2b2ljZS5jb20vcG9kY2FzdC94bWwvYWxidW0yMDIzL29uY29sb2d5X2hhZW1hdG9sb2d5X2F1ZGlvLmpwZw==.jpg)
D. Ross Camidge, MD, PhD - Mastering MET and cMET and Recognizing Their Role in Advanced NSCLC
D. Ross Camidge, MD, PhD - Mastering MET and cMET and Recognizing Their Role in Advanced NSCLC
D. Ross Camidge, MD, PhD - Mastering MET and cMET and Recognizing Their Role in Advanced NSCLC
27 Jun 2023
•
55mins
![Podcast cover](https://cdn-images.owltail.com/200x/jpg/aHR0cHM6Ly9jLnBlZXJ2b2ljZS5jb20vcG9kY2FzdC94bWwvYWxidW0yMDIzL29uY29sb2d5X2hhZW1hdG9sb2d5X2F1ZGlvLmpwZw==.jpg)
Kevin Harrington, PhD, FRCR, FRCP - After More Than a Decade: Can We Now Enhance Treatment of Patients With LA SCCHN?
Kevin Harrington, PhD, FRCR, FRCP - After More Than a Decade: Can We Now Enhance Treatment of Patients With LA SCCHN?
Kevin Harrington, PhD, FRCR, FRCP - After More Than a Decade: Can We Now Enhance Treatment of Patients With LA SCCHN?
27 Jun 2023
•
1hr
![Podcast cover](https://cdn-images.owltail.com/200x/jpg/aHR0cHM6Ly9jLnBlZXJ2b2ljZS5jb20vcG9kY2FzdC94bWwvYWxidW0yMDIzL29uY29sb2d5X2hhZW1hdG9sb2d5X2F1ZGlvLmpwZw==.jpg)
Arndt Vogel, MD - Options and Opportunities in Cholangiocarcinoma: Novel Approaches for Targeting FGFR Alterations
Arndt Vogel, MD - Options and Opportunities in Cholangiocarcinoma: Novel Approaches for Targeting FGFR Alterations
Arndt Vogel, MD - Options and Opportunities in Cholangiocarcinoma: Novel Approaches for Targeting FGFR Alterations
19 Jun 2023
•
25mins
![Podcast cover](https://cdn-images.owltail.com/200x/jpg/aHR0cHM6Ly9jLnBlZXJ2b2ljZS5jb20vcG9kY2FzdC94bWwvYWxidW0yMDIzL29uY29sb2d5X2hhZW1hdG9sb2d5X2F1ZGlvLmpwZw==.jpg)
Sara A. Hurvitz, MD, FACP - Drug-Induced Interstitial Lung Disease and Breast Cancer: Knowing the Odds and Managing the Risk
Sara A. Hurvitz, MD, FACP - Drug-Induced Interstitial Lung Disease and Breast Cancer: Knowing the Odds and Managing the Risk
Sara A. Hurvitz, MD, FACP - Drug-Induced Interstitial Lung Disease and Breast Cancer: Knowing the Odds and Managing the ... Read more
19 Jun 2023
•
30mins